A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the potential to protect humans from developing HIV infection and AIDS. This HIV ...

A new HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists, and IAVI has the ...

Cambridge scientists have pushed a new kind of “universal” coronavirus vaccine into first-in-human testing, betting that a ...

A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...

Objectives To evaluate knowledge, attitudes and practices towards routine vaccination in the Lebanese population in the post-COVID-19 period, and to examine differences between COVID-19 vaccinated and ...

Fujifilm outlived the decline of traditional photography and has logged record profits after diversifying into a wide range ...

An experimental mRNA vaccine delayed neuroblastoma growth and sharply reduced tumor size in preclinical models.

Lipid-based nanocarriers, particularly liposomes, have played a central role in the development of modern drug delivery ...

Medical advancements over the last several decades have made great strides in the treatment of HIV. Pharmaceutical treatments are able to contain and reduce a patient's viral load to the point where ...

Nanotechnology has quietly progressed through three distinct generations, and the third is now reshaping how deep-tech R&D itself must be organized.

Biotechnology organizations are turning in growing numbers to alternative strategies centered on strengthening the performance of already-approved drugs. Oncotelic Therapeutics is developing ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest healthcare news straight to your inbox. Subscribe here to receive future editions. Eli Lilly 's ...